William P. Quinn - Net Worth and Insider Trading

William P. Quinn Net Worth

The estimated net worth of William P. Quinn is at least $43,274 dollars as of 2024-11-05. William P. Quinn is the CFO of Bolt Biotherapeutics Inc and owns about 36,272 shares of Bolt Biotherapeutics Inc (BOLT) stock worth over $23,867. William P. Quinn is also the See Remarks of Sunesis Pharmaceuticals Inc and owns about 3,648 shares of Sunesis Pharmaceuticals Inc (SNSS) stock worth over $19,407. Details can be seen in William P. Quinn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William P. Quinn has not made any transactions after 2023-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of William P. Quinn

To

William P. Quinn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William P. Quinn owns 3 companies in total, including Sunesis Pharmaceuticals Inc (SNSS) , Viracta Therapeutics Inc (VIRX) , and Bolt Biotherapeutics Inc (BOLT) .

Click here to see the complete history of William P. Quinn’s form 4 insider trades.

Insider Ownership Summary of William P. Quinn

Ticker Comapny Transaction Date Type of Owner
SNSS Sunesis Pharmaceuticals Inc 2020-03-31 See Remarks
VIRX Viracta Therapeutics Inc 2019-02-28 See Remarks
BOLT Bolt Biotherapeutics Inc 2023-12-12 Chief Financial Officer

William P. Quinn Latest Holdings Summary

William P. Quinn currently owns a total of 2 stocks. Among these stocks, William P. Quinn owns 36,272 shares of Bolt Biotherapeutics Inc (BOLT) as of December 12, 2023, with a value of $23,867 and a weighting of 55.15%. William P. Quinn also owns 3,648 shares of Sunesis Pharmaceuticals Inc (SNSS) as of November 29, 2019, with a value of $19,407 and a weighting of 44.85%.

Latest Holdings of William P. Quinn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BOLT Bolt Biotherapeutics Inc 2023-12-12 36,272 0.66 23,867
SNSS Sunesis Pharmaceuticals Inc 2019-11-29 3,648 5.32 19,407

Holding Weightings of William P. Quinn


William P. Quinn Form 4 Trading Tracker

According to the SEC Form 4 filings, William P. Quinn has made a total of 3 transactions in Bolt Biotherapeutics Inc (BOLT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Bolt Biotherapeutics Inc is the acquisition of 11,829 shares on December 12, 2023, which cost William P. Quinn around $11,238.

According to the SEC Form 4 filings, William P. Quinn has made a total of 1 transactions in Sunesis Pharmaceuticals Inc (SNSS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sunesis Pharmaceuticals Inc is the acquisition of 343 shares on November 29, 2019, which cost William P. Quinn around $6,120.

Insider Trading History of William P. Quinn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William P. Quinn Trading Performance

GuruFocus tracks the stock performance after each of William P. Quinn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William P. Quinn is 29.39%. GuruFocus also compares William P. Quinn's trading performance to market benchmark return within the same time period. The performance of stocks bought by William P. Quinn within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how William P. Quinn's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of William P. Quinn

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.84 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.2 LIMIT LIMIT LIMIT LIMIT LIMIT

William P. Quinn Ownership Network

Ownership Network List of William P. Quinn

No Data

Ownership Network Relation of William P. Quinn

Insider Network Chart

William P. Quinn Owned Company Details

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

William P. Quinn is the See Remarks of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks Judith A. Fox .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

William P. Quinn Mailing Address

Above is the net worth, insider trading, and ownership report for William P. Quinn. You might contact William P. Quinn via mailing address: Sunesis Pharmaceuticals, Inc., 395 Oyster Point Boulevard, Suite 400, South San Francisco Ca 94080.